The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd
Abstract Mycobacterial energy metabolism currently attracts strong attention as new target space for development of anti-tuberculosis drugs. The imidazopyridine Q203 targets the cytochrome bcc complex of the respiratory chain, a key component in energy metabolism. Q203 blocks growth of Mycobacterium...
Guardado en:
Autores principales: | Ping Lu, Amer H. Asseri, Martijn Kremer, Janneke Maaskant, Roy Ummels, Holger Lill, Dirk Bald |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3ff05a4c9b840efb2333c8bfd9914f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo 3 solubilized in dodecyl-maltoside
por: Amer H. Asseri, et al.
Publicado: (2021) -
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Shan Zhou, et al.
Publicado: (2021) -
Cryo-EM structure of mycobacterial cytochrome bd reveals two oxygen access channels
por: Weiwei Wang, et al.
Publicado: (2021) -
Structure of Escherichia coli cytochrome bd-II type oxidase with bound aurachin D
por: Antonia Grauel, et al.
Publicado: (2021) -
Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals
por: Connor J. Beebout, et al.
Publicado: (2021)